{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:53:50Z","timestamp":1792670030328,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-022-02729-y","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T22:02:38Z","timestamp":1668031358000},"page":"102-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Stable CAD patients show higher levels of platelet-borne TGF-\u03b21 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-\u03b21 in atherosclerosis"],"prefix":"10.1007","volume":"55","author":[{"given":"Javad","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehteramolsadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Kargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-5649","authenticated-orcid":false,"given":"Mehran","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"6","key":"2729_CR1","doi-asserted-by":"crossref","first-page":"030006051989643","DOI":"10.1177\/0300060519896437","volume":"48","author":"C Song","year":"2020","unstructured":"Song C, Wu G, Chang S, Bie L (2020) Plasma P-selectin level is associated with severity of coronary heart disease in Chinese Han population. J Int Med Res 48(6):0300060519896437","journal-title":"J Int Med Res"},{"issue":"02","key":"2729_CR2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0038-1676563","volume":"119","author":"M Tscharre","year":"2019","unstructured":"Tscharre M, Vogel B, Tentzeris I, Freynhofer MK, Rohla M, Wojta J et al (2019) Prognostic impact of soluble P-selectin on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Thromb Haemost 119(02):340\u2013347","journal-title":"Thromb Haemost"},{"key":"2729_CR3","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.12659\/MSM.910707","volume":"24","author":"S Wang","year":"2018","unstructured":"Wang S, Zhang Q, Wang Y, You B, Meng Q, Zhang S et al (2018) Transforming growth factor \u03b21 (TGF-\u03b21) appears to promote coronary artery disease by upregulating sphingosine kinase 1 (SPHK1) and further upregulating its downstream TIMP-1. Med Sci Monit: Int Med J Exp Clin Res 24:7322","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"issue":"24","key":"2729_CR4","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","volume":"357","author":"G Dav\u00ec","year":"2007","unstructured":"Dav\u00ec G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357(24):2482\u20132494","journal-title":"N Engl J Med"},{"issue":"1","key":"2729_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-016-2756-4","volume":"419","author":"R George","year":"2016","unstructured":"George R, Bhatt A, Narayani J, Thulaseedharan JV, Sivadasanpillai H, Tharakan JA (2016) Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease. Mol Cell Biochem 419(1):125\u2013133","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"2729_CR6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1160\/TH11-08-0592","volume":"106","author":"D Lievens","year":"2011","unstructured":"Lievens D, von Hundelshausen P (2011) Platelets in atherosclerosis. Thromb Haemost 106(11):827\u2013838","journal-title":"Thromb Haemost"},{"issue":"8","key":"2729_CR7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB et al (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14(8):812\u2013820","journal-title":"Nat Immunol"},{"issue":"3\u20134","key":"2729_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(01)00111-6","volume":"11","author":"JL Witztum","year":"2001","unstructured":"Witztum JL, Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 11(3\u20134):93\u2013102","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"2729_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0891-5849(90)90119-4","volume":"9","author":"UP Steinbrecher","year":"1990","unstructured":"Steinbrecher UP, Zhang H, Lougheed M (1990) Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol Med 9(2):155\u2013168","journal-title":"Free Radical Biol Med"},{"key":"2729_CR10","volume":"141","author":"P Ropraz","year":"2018","unstructured":"Ropraz P, Imhof BA, Matthes T, Wehrle-Haller B, Sidib\u00e9 A (2018) Simultaneous study of the recruitment of monocyte subpopulations under flow in vitro. JoVE (J V Exp) 141:e58509","journal-title":"JoVE (J V Exp)"},{"key":"2729_CR11","unstructured":"Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. The American journal of pathology. 1981;103(2):181."},{"issue":"3","key":"2729_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvv147","volume":"107","author":"T Gerhardt","year":"2015","unstructured":"Gerhardt T, Ley K (2015) Monocyte trafficking across the vessel wall. Cardiovasc Res 107(3):321\u2013330","journal-title":"Cardiovasc Res"},{"key":"2729_CR13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fimmu.2019.00834","volume":"10","author":"YC Teh","year":"2019","unstructured":"Teh YC, Ding JL, Ng LG, Chong SZ (2019) Capturing the fantastic voyage of monocytes through time and space. Front Immunol 10:834","journal-title":"Front Immunol"},{"issue":"2","key":"2729_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/HYPERTENSIONAHA.107.089854","volume":"50","author":"CA Gleissner","year":"2007","unstructured":"Gleissner CA, Leitinger N, Ley K (2007) Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension 50(2):276\u2013283","journal-title":"Hypertension"},{"issue":"2","key":"2729_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.thromres.2011.09.026","volume":"129","author":"N Alexandru","year":"2012","unstructured":"Alexandru N, Popov D, Georgescu A (2012) Platelet dysfunction in vascular pathologies and how can it be treated. Thromb Res 129(2):116\u2013126","journal-title":"Thromb Res"},{"issue":"7","key":"2729_CR16","first-page":"2661","volume":"101","author":"PC Burger","year":"2003","unstructured":"Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood J Am Soc Hematol 101(7):2661\u20132666","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"2729_CR17","doi-asserted-by":"crossref","DOI":"10.1116\/1.4953246","volume":"11","author":"M Reinthaler","year":"2016","unstructured":"Reinthaler M, Braune S, Lendlein A, Landmesser U, Jung F (2016) Platelets and coronary artery disease: interactions with the blood vessel wall and cardiovascular devices. Biointerphases 11(2):029702","journal-title":"Biointerphases"},{"issue":"2","key":"2729_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","volume":"2","author":"L Gu","year":"1998","unstructured":"Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P et al (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor\u2013deficient mice. Mol Cell 2(2):275\u2013281","journal-title":"Mol Cell"},{"issue":"8","key":"2729_CR19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1253\/circj.CJ-14-0621","volume":"78","author":"F De Paoli","year":"2014","unstructured":"De Paoli F, Staels B, Chinetti-Gbaguidi G (2014) Macrophage phenotypes and their modulation in atherosclerosis. Circ J 78(8):1775\u20131781","journal-title":"Circ J"},{"key":"2729_CR20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2014.00579","volume":"5","author":"M Peled","year":"2014","unstructured":"Peled M, Fisher EA (2014) Dynamic aspects of macrophage polarization during atherosclerosis progression and regression. Front Immunol 5:579","journal-title":"Front Immunol"},{"issue":"1","key":"2729_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cvr\/cvn015","volume":"78","author":"D Siegel-Axel","year":"2008","unstructured":"Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M (2008) Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 78(1):8\u201317","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2729_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","volume":"34","author":"S Badrnya","year":"2014","unstructured":"Badrnya S, Schrottmaier WC, Kral JB, Yaiw K-C, Volf I, Schabbauer G et al (2014) Platelets mediate oxidized low-density lipoprotein\u2013induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol 34(3):571\u2013580","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2729_CR23","first-page":"1047","volume":"98","author":"V Henn","year":"2001","unstructured":"Henn V, Steinbach S, B\u00fcchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood J Am Soc Hematol 98(4):1047\u20131054","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"2729_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","volume":"8","author":"P Andre","year":"2002","unstructured":"Andre P, Prasad K, Denis CV, He M, Papalia JM, Hynes RO et al (2002) CD40L stabilizes arterial thrombi by a \u03b23 integrin\u2013dependent mechanism. Nat Med 8(3):247\u2013252","journal-title":"Nat Med"},{"issue":"12","key":"2729_CR25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1253\/circj.71.1857","volume":"71","author":"AA Youssef","year":"2007","unstructured":"Youssef AA, Chang L-T, Sheu J-J, Lee F-Y, Chu S, Yeh K-H et al (2007) Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention. Circ J 71(12):1857\u20131861","journal-title":"Circ J"},{"issue":"6","key":"2729_CR26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00125-005-1750-2","volume":"48","author":"F Cipollone","year":"2005","unstructured":"Cipollone F, Chiarelli F, Davi G, Ferri C, Desideri G, Fazia M et al (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48(6):1216\u20131224","journal-title":"Diabetologia"},{"issue":"5","key":"2729_CR27","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.94.5.1931","volume":"94","author":"F Mach","year":"1997","unstructured":"Mach F, Sch\u00f6nbeck U, Sukhova GK, Bourcier T, Bonnefoy J-Y, Pober JS et al (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40\u2013CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci 94(5):1931\u20131936","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"2729_CR28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","volume":"14","author":"M Rizvi","year":"2008","unstructured":"Rizvi M, Pathak D, Freedman JE, Chakrabarti S (2008) CD40\u2013CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med 14(12):530\u2013538","journal-title":"Trends Mol Med"},{"issue":"11","key":"2729_CR29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.111.247684","volume":"109","author":"D Wolf","year":"2011","unstructured":"Wolf D, Hohmann J-D, Wiedemann A, Bledzka K, Blankenbach H, Marchini T et al (2011) Binding of CD40L to Mac-1\u2019s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis\u2014but does not affect immunity and thrombosis in mice. Circ Res 109(11):1269\u20131279","journal-title":"Circ Res"},{"issue":"1","key":"2729_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-019-0209-5","volume":"17","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Mohtashami M, Ghasemzadeh M (2019) Down-regulation of platelet adhesion receptors is a controlling mechanism of thrombosis, while also affecting post-transfusion efficacy of stored platelets. Thromb J 17(1):1\u201311","journal-title":"Thromb J"},{"issue":"3","key":"2729_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11239-019-01916-8","volume":"48","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Ghasemzadeh M, Azizvakili E, Beshkar P (2019) Platelet spreading on fibrinogen matrix, a reliable and sensitive marker of platelet functional activity during storage. J Thromb Thrombolysis 48(3):430\u2013438","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"2729_CR32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.thromres.2010.10.010","volume":"127","author":"Z Li","year":"2011","unstructured":"Li Z, Yang F, Dunn S, Gross AK, Smyth SS (2011) Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 127(3):184\u2013188","journal-title":"Thromb Res"},{"issue":"1","key":"2729_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","volume":"15","author":"RR Koenen","year":"2009","unstructured":"Koenen RR, Von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A et al (2009) Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15(1):97\u2013103","journal-title":"Nat Med"},{"issue":"13","key":"2729_CR34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.103.13.1772","volume":"103","author":"P Von Hundelshausen","year":"2001","unstructured":"Von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K et al (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103(13):1772\u20131777","journal-title":"Circulation"},{"issue":"6","key":"2729_CR35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.ATV.0000019729.39500.2F","volume":"22","author":"E Lutgens","year":"2002","unstructured":"Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE et al (2002) Transforming growth factor-\u03b2 mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22(6):975\u2013982","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2729_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00441-011-1189-3","volume":"347","author":"I Toma","year":"2012","unstructured":"Toma I, McCaffrey TA (2012) Transforming growth factor-\u03b2 and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell Tissue Res 347(1):155\u2013175","journal-title":"Cell Tissue Res"},{"key":"2729_CR37","doi-asserted-by":"crossref","unstructured":"Poniatowski \u0141A, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators of inflammation. 2015;2015.","DOI":"10.1155\/2015\/137823"},{"issue":"1","key":"2729_CR38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"M-J Goumans","year":"2009","unstructured":"Goumans M-J, Liu Z, Ten Dijke P (2009) TGF-\u03b2 signaling in vascular biology and dysfunction. Cell Res 19(1):116\u2013127","journal-title":"Cell Res"},{"key":"2729_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cellsig.2018.09.004","volume":"53","author":"EL Low","year":"2019","unstructured":"Low EL, Baker AH, Bradshaw AC (2019) TGF\u03b2, smooth muscle cells and coronary artery disease: a review. Cell Signal 53:90\u2013101","journal-title":"Cell Signal"},{"issue":"3","key":"2729_CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.ATV.0000114567.76772.33","volume":"24","author":"DJ Grainger","year":"2004","unstructured":"Grainger DJ (2004) Transforming growth factor \u03b2 and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24(3):399\u2013404","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2729_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cytogfr.2006.09.002","volume":"17","author":"NN Singh","year":"2006","unstructured":"Singh NN, Ramji DP (2006) The role of transforming growth factor-\u03b2 in atherosclerosis. Cytokine Growth Factor Rev 17(6):487\u2013499","journal-title":"Cytokine Growth Factor Rev"},{"key":"2729_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/res.89.10.853","author":"E Lutgens","year":"2001","unstructured":"Lutgens E, Daemen MJ (2001) Transforming growth factor-\u03b2: a local or systemic mediator of plaque stability? Circ Res. https:\/\/doi.org\/10.1161\/res.89.10.853","journal-title":"Circ Res"},{"issue":"10","key":"2729_CR43","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/01.STR.0000140739.45472.9c","volume":"35","author":"F Cipollone","year":"2004","unstructured":"Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C et al (2004) Increased expression of transforming growth factor-\u03b21 as a stabilizing factor in human atherosclerotic plaques. Stroke 35(10):2253\u20132257","journal-title":"Stroke"},{"key":"2729_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.121.316233","author":"A Yurdagul Jr","year":"2022","unstructured":"Yurdagul A Jr (2022) Crosstalk between macrophages and vascular smooth muscle cells in atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316233","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2729_CR45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/FJC.0000000000000813","volume":"75","author":"Z He","year":"2020","unstructured":"He Z, Xue H, Liu P, Han D, Xu L, Zeng X et al (2020) miR-4286\/TGF-\u03b21\/Smad3-negative feedback loop ameliorated vascular endothelial cell damage by attenuating apoptosis and inflammatory response. J Cardiovasc Pharmacol 75(5):446\u2013454","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"2729_CR46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nm0995-932","volume":"1","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGF\u2013\u03b2 in blood clots during dissolution with plasmin. Nat Med 1(9):932\u2013937","journal-title":"Nat Med"},{"issue":"2","key":"2729_CR47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(97)00033-3","volume":"34","author":"X Wang","year":"1997","unstructured":"Wang X, Liu S-X, Wilcken D (1997) Circulating transforming growth factor \u03b21 and coronary artery disease. Cardiovasc Res 34(2):404\u2013410","journal-title":"Cardiovasc Res"},{"issue":"9","key":"2729_CR48","first-page":"3650","volume":"112","author":"J Ahamed","year":"2008","unstructured":"Ahamed J, Burg N, Yoshinaga K, Janczak CA, Rifkin DB, Coller BS (2008) In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-\u03b21. Blood J Am Soc Hematol 112(9):3650\u20133660","journal-title":"Blood J Am Soc Hematol"},{"key":"2729_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)32345-7","author":"RK Assoian","year":"1983","unstructured":"Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets identification of a major storage site, purification, and characterization. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(18)32345-7","journal-title":"J Biol Chem"},{"issue":"4","key":"2729_CR50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11239-020-02080-0","volume":"49","author":"F Negro","year":"2020","unstructured":"Negro F, Verdoia M, Tonon F, Nardin M, Kedhi E, De Luca G (2020) Impact of gender on immature platelet count and its relationship with coronary artery disease. J Thromb Thrombolysis 49(4):511\u2013521","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2729_CR51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","volume":"31","author":"MI Furman","year":"1998","unstructured":"Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC et al (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31(2):352\u2013358","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2729_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-019-01312-3","volume":"20","author":"L Shen","year":"2020","unstructured":"Shen L, Yang T, Xia K, Yan Z, Tan J, Li L et al (2020) P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study. BMC Cardiovasc Disord 20(1):1\u20137","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"2729_CR53","first-page":"3205","volume":"112","author":"C Chen","year":"2008","unstructured":"Chen C, Chai H, Wang X, Jiang J, Jamaluddin MS, Liao D et al (2008) Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood J Am Soc Hematol 112(8):3205\u20133216","journal-title":"Blood J Am Soc Hematol"},{"issue":"20","key":"2729_CR54","first-page":"4317","volume":"116","author":"D Lievens","year":"2010","unstructured":"Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC et al (2010) Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood J Am Soc Hematol 116(20):4317\u20134327","journal-title":"Blood J Am Soc Hematol"},{"key":"2729_CR55","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.01.58","author":"P Napole\u00e3o","year":"2017","unstructured":"Napole\u00e3o P, Carmo MM, Pinheiro T (2017) Prognostic evaluation of soluble CD40L in acute myocardial infarction: is not fancy, is science! Ann Trans Med. https:\/\/doi.org\/10.21037\/atm.2017.01.58","journal-title":"Ann Trans Med"},{"issue":"1","key":"2729_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23909-z","volume":"12","author":"M Lacy","year":"2021","unstructured":"Lacy M, B\u00fcrger C, Shami A, Ahmadsei M, Winkels H, Nitz K et al (2021) Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun 12(1):1\u201312","journal-title":"Nat Commun"},{"issue":"4","key":"2729_CR57","first-page":"329","volume":"10","author":"T Pereira-da-Silva","year":"2020","unstructured":"Pereira-da-Silva T, Napoleao P, Pinheiro T, Selas M, Silva F, Ferreira RC et al (2020) Inflammation is associated with the presence and severity of chronic coronary syndrome through soluble CD40 ligand. Am J Cardiovasc Dis 10(4):329","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"2729_CR58","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3329\/bjms.v20i4.54137","volume":"20","author":"L Rosita","year":"2021","unstructured":"Rosita L, Marfianti E, Devita N, Arjana AZ (2021) CD40L-CD40 interaction avidity as coronary artery disease predictive factor. Bangladesh J Med Sci 20(4):796\u2013800","journal-title":"Bangladesh J Med Sci"},{"key":"2729_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.684920","author":"G Baidildinova","year":"2021","unstructured":"Baidildinova G, Nagy M, Jurk K, Wild PS, Ten Cate H, Van der Meijden PE (2021) Soluble platelet release factors as biomarkers for cardiovascular disease. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.684920","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2729_CR60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/diabetes.54.3.811","volume":"54","author":"S Redondo","year":"2005","unstructured":"Redondo S, Ruiz E, Santos-Gallego CG, Padilla E, Tejerina T (2005) Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-\u03b3, transforming growth factor-\u03b21, and a Smad2-dependent mechanism. Diabetes 54(3):811\u2013817","journal-title":"Diabetes"},{"issue":"3\u20134","key":"2729_CR61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cytogfr.2007.04.005","volume":"18","author":"S Redondo","year":"2007","unstructured":"Redondo S, Santos-Gallego CG, Tejerina T (2007) TGF-\u03b21: a novel target for cardiovascular pharmacology. Cytokine Growth Factor Rev 18(3\u20134):279\u2013286","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2729_CR62","doi-asserted-by":"crossref","first-page":"H540","DOI":"10.1152\/ajpheart.91478.2007","volume":"297","author":"S Tsai","year":"2009","unstructured":"Tsai S, Hollenbeck ST, Ryer EJ, Edlin R, Yamanouchi D, Kundi R et al (2009) TGF-\u03b2 through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol-Heart Circ Physiol 297(2):H540\u2013H549","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"2729_CR63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.matbio.2018.02.019","volume":"71","author":"TN Wight","year":"2018","unstructured":"Wight TN (2018) A role for proteoglycans in vascular disease. Matrix Biol 71:396\u2013420","journal-title":"Matrix Biol"},{"issue":"8","key":"2729_CR64","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.P040139","volume":"54","author":"T Tang","year":"2013","unstructured":"Tang T, Wilson PG, Thompson JC, Nelson C, Yoder MH, Tannock LR (2013) Prevention of TGF\u03b2 induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr\u2212\/\u2212 mice1. J Lipid Res 54(8):2255\u20132264","journal-title":"J Lipid Res"},{"issue":"2","key":"2729_CR65","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.1300272","volume":"194","author":"D Nurgazieva","year":"2015","unstructured":"Nurgazieva D, Mickley A, Moganti K, Ming W, Ovsyi I, Popova A et al (2015) TGF-\u03b21, but not bone morphogenetic proteins, activates Smad1\/5 pathway in primary human macrophages and induces expression of proatherogenic genes. J Immunol 194(2):709\u2013718","journal-title":"J Immunol"},{"issue":"22","key":"2729_CR66","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.99.22.2883","volume":"99","author":"A Bobik","year":"1999","unstructured":"Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V et al (1999) Distinct patterns of transforming growth factor-\u03b2 isoform and receptor expression in human atherosclerotic lesions: colocalization implicates TGF-\u03b2 in fibrofatty lesion development. Circulation 99(22):2883\u20132891","journal-title":"Circulation"},{"issue":"11","key":"2729_CR67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.it.2007.08.010","volume":"28","author":"G Murugaiyan","year":"2007","unstructured":"Murugaiyan G, Martin S, Saha B (2007) CD40-induced countercurrent conduits for tumor escape or elimination? Trends Immunol 28(11):467\u2013473","journal-title":"Trends Immunol"},{"issue":"9","key":"2729_CR68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s42255-019-0102-3","volume":"1","author":"P-Y Chen","year":"2019","unstructured":"Chen P-Y, Qin L, Li G, Wang Z, Dahlman JE, Malagon-Lopez J et al (2019) Endothelial TGF-\u03b2 signalling drives vascular inflammation and atherosclerosis. Nat Metab 1(9):912\u2013926","journal-title":"Nat Metab"},{"issue":"1","key":"2729_CR69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm0195-74","volume":"1","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR et al (1995) The serum concentration of active transforming growth factor-\u03b2 is severely depressed in advanced atherosclerosis. Nat Med 1(1):74\u201379","journal-title":"Nat Med"},{"issue":"10","key":"2729_CR70","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.19.10.2355","volume":"19","author":"M Erren","year":"1999","unstructured":"Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19(10):2355\u20132363","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2729_CR71","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.atherosclerosis.2014.10.021","volume":"237","author":"D Rath","year":"2014","unstructured":"Rath D, Chatterjee M, M\u00fcller I, M\u00fcller K, B\u00f6ckmann C, Droppa M et al (2014) Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome. Atherosclerosis 237(2):754\u2013759","journal-title":"Atherosclerosis"},{"issue":"10","key":"2729_CR72","first-page":"4162","volume":"8","author":"LE Gentry","year":"1988","unstructured":"Gentry LE, Lioubin M, Purchio AF, Marquardt H (1988) Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 8(10):4162\u20134168","journal-title":"Mol Cell Biol"},{"key":"2729_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68547-3","author":"L Wakefield","year":"1988","unstructured":"Wakefield L, Smith D, Flanders K, Sporn M (1988) Latent transforming growth factor-beta from human platelets a high molecular weight complex containing precursor sequences. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(18)68547-3","journal-title":"J Biol Chem"},{"issue":"5","key":"2729_CR74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000025281","volume":"27","author":"A Matzdorff","year":"2000","unstructured":"Matzdorff A (2000) Evaluation of platelet activation in coronary artery disease\u2013the role of flow cytometry. Trans Med Hemotherapy 27(5):237\u2013242","journal-title":"Trans Med Hemotherapy"},{"issue":"5","key":"2729_CR75","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.111.243485","volume":"32","author":"O Postea","year":"2012","unstructured":"Postea O, Vasina EM, Cauwenberghs S, Projahn D, Liehn EA, Lievens D et al (2012) Contribution of platelet CX3CR1 to platelet\u2013monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol 32(5):1186\u20131193","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2729_CR76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4070\/kcj.2015.45.5.378","volume":"45","author":"S-J Joo","year":"2015","unstructured":"Joo S-J, Choi J-H, Kim S-Y, Kim K-S, Kim YR, Kang SH (2015) An assay of measuring platelet reactivity using monoclonal antibody against activated platelet glycoprotein IIb\/IIIa in patients taking clopidogrel. Korean Circ J 45(5):378\u2013385","journal-title":"Korean Circ J"},{"key":"2729_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02462.x","author":"MD Linden","year":"2007","unstructured":"Linden MD, Furman MI, FRELINGER III AL, Fox ML, Barnard MR, Li Y, et al (2007) Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02462.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2729_CR78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/09537104.2010.547959","volume":"22","author":"V Yakushkin","year":"2011","unstructured":"Yakushkin V, Zyuryaev I, Khaspekova S, Sirotkina O, Ruda MY, Mazurov A (2011) Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome. Platelets 22(4):243\u2013251","journal-title":"Platelets"},{"key":"2729_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.08.023","author":"CG Santos-Gallego","year":"2014","unstructured":"Santos-Gallego CG, Badimon JJ (2014) The sum of two evils. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2014.08.023","journal-title":"J Am Coll Cardiol"},{"key":"2729_CR80","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjcard.2020.12.018","volume":"144","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Badimon J (2021) Overview of aspirin and platelet biology. Am J Cardiol 144:S2\u2013S9","journal-title":"Am J Cardiol"},{"issue":"4","key":"2729_CR81","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000045664.75269.A5","volume":"107","author":"S Redondo","year":"2003","unstructured":"Redondo S, Santos-Gallego CG, Ganado P, Garc\u00eda M, Rico L, Del Rio M et al (2003) Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-\u03b2. Circulation 107(4):626\u2013629","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-022-02729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:28:26Z","timestamp":1676363306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-022-02729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["2729"],"URL":"https:\/\/doi.org\/10.1007\/s11239-022-02729-y","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"28 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the High Institute for Research and Education in Transfusion Medicine, Tehran, Iran (Ethic approval number: IR.TMI.REC.1398.012).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}